Cantor Fitzgerald Maintains Overweight on CVRx, Lowers Price Target to $5

Benzinga · 2d ago
Cantor Fitzgerald analyst Sarah James maintains CVRx (NASDAQ:CVRX) with a Overweight and lowers the price target from $13 to $5.